Seiwerth, S., Milavic, M., Vukojevic, J., Gojkovic, S., Krezic, I., Vuletic, L
Numerous delivery strategies, e.g., nanocarriers, MOFs, and stimuli-responsive systems, have been developed to mitigate these issues, but they often suffer from inherent limitations such as uncontrolled release, insufficient targeting, and unresolved long-term toxicity, which can still lead to potential cytotoxicity and systemic biosafety concerns [19]
Without DAC for Ipamorelin pairing
Disclaimer: This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease
Asanuma M, Miyazaki I